Bonus BioGroup Ltd. (TLV:BONS)
25.50
-0.40 (-1.54%)
Dec 30, 2025, 11:48 AM IDT
Bonus BioGroup Market Cap
Bonus BioGroup has a market cap or net worth of 302.49 million as of December 30, 2025. Its market cap has increased by 139.81% in one year.
Market Cap
302.49M
Enterprise Value
310.90M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
25.50
Market Cap Chart
Since July 25, 2012, Bonus BioGroup's market cap has increased from 12.36M to 302.49M, an increase of 2,346.84%. That is a compound annual growth rate of 26.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 29, 2025 | 302.49M | 117.65% |
| Dec 31, 2024 | 138.98M | -28.74% |
| Dec 31, 2023 | 195.04M | -13.02% |
| Dec 29, 2022 | 224.24M | -84.58% |
| Dec 30, 2021 | 1.45B | 200.74% |
| Dec 31, 2020 | 483.51M | 29.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 116.93B |
| Danel (Adir Yeoshua) | 2.90B |
| Kamada | 1.30B |
| BrainsWay | 1.23B |
| SofWave Medical | 1.04B |
| Bait Bakfar | 1.00B |
| Ilex Medical | 752.85M |
| Novolog (Pharm-Up 1966) | 668.22M |